Go to the list of all blogs
published in Blogs
Jul 13, 2026
Life360 (LIF) Climbs +16% in 30 Days With +32% Quarterly Advance

Life360 (LIF) Climbs +16% in 30 Days With +32% Quarterly Advance

Key Takeaways

  • Life360 (LIF) shares gained approximately 16% over the last 30 days, rising from around $45.25 to $52.32, as of intraday trading on July 13, 2026.
  • The stock has surged roughly 32% over the past quarter, reflecting accelerating revenue growth, advertising momentum, and improving investor sentiment.
  • Q1 2026 earnings delivered a massive EPS beat, generating $0.11 per share versus consensus estimates of a $0.02 loss, alongside 38% year-over-year revenue growth to $143.1 million.
  • A newly expanded Uber partnership, a $225 million share repurchase program, and the rapid scaling of advertising revenue following the Nativo acquisition served as notable catalysts.
  • Analyst sentiment remains broadly positive, with Citi raising its price target to $66.65 in early July and a consensus rating of "Moderate Buy" across Wall Street coverage.

Life360's Platform and Competitive Position

Life360, Inc. runs a family safety and connectivity platform with nearly 98 million monthly active users worldwide. Its main mobile app offers real-time location sharing, crash detection, driving safety reports, digital safety tools, and emergency assistance on a freemium basis. Premium subscriptions, known as Paying Circles, range from $7.99 to $24.99 per month and unlock additional features. The company also owns Tile, a well-known brand of Bluetooth tracking devices, and has moved into pet GPS hardware. Headquartered in San Mateo, California, Life360 listed on Nasdaq in June 2024 under the ticker LIF. Its edge comes from a large, proprietary first-party location dataset that synthetic AI models cannot easily replicate, which adds value for both subscribers and advertisers. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Stock Performance Over the Past 30 Days and Quarter

Over the last 30 calendar days, LIF shares rose from a closing price of $45.25 on June 12, 2026, to an intraday level of $52.32 on July 13, 2026 — a gain of roughly 16%. The advance included a sharp rally in late June, moving from $48.94 on June 25 to $53.08 on June 26 and touching an intra-quarter high of $57.71 on July 2.

Looking at the broader quarter, performance has been even stronger. From a close of $39.52 on April 13, the stock has appreciated approximately 32%. This recovery follows a sell-off in early-to-mid May, when shares fell as low as $37.65 on May 12 amid temporary technical issues that slowed monthly active user registrations. The rebound since then highlights the market’s focus on the underlying business momentum.

Drivers Behind the Recent 30-Day Gain

Several factors supported LIF’s double-digit move over the trailing 30 days. Investors continued to absorb the Q1 2026 earnings report from mid-May, which showed adjusted EPS of $0.11 versus an expected loss and revenue of $143.1 million — up 38% from the prior-year quarter. Subscription revenue grew 32% to $108.2 million, while advertising revenue jumped 329% to $19.7 million after the January 2026 Nativo acquisition.

On June 18, Life360 and Uber Technologies (UBER) announced an expanded integration that lets parents book Uber rides for teens directly in the Life360 app and track trips in real time. This reinforces the company’s role as a full family safety platform. The board also authorized a $225 million multi-year share repurchase program, which signals confidence in the stock’s long-term value. Institutional buying has helped as well, with firms such as the New York State Teachers Retirement System adding new positions in the first quarter. Citi raised its price target on LIF to $66.65 on July 6 while keeping a Buy rating, and the broader consensus remains at “Moderate Buy” with an average target near $62.46.

Quarterly Momentum and Business Transition

The bigger quarterly story centers on Life360’s shift from a pure subscription model to a platform with multiple revenue streams. The Nativo acquisition turned the advertising business into a full-stack operation that reaches over 95% of ad-eligible U.S. adults across more than 20,000 publisher sites and connected TV. Advertising revenue, now reported separately, is on track to reach $98 million to $115 million for fiscal 2026.

Subscription growth stayed solid, with Paying Circles topping 3 million for the first time and average revenue per paying circle hitting an all-time high. International markets in the U.K., Canada, and Australia saw Paying Circles growth of 25% to 32%. Temporary MAU registration issues in Q1 weighed on user metrics, but management has confirmed the fixes are complete and guided for full-year MAU growth of 17% to 20%. Full-year revenue guidance was raised to $650 million to $685 million, with adjusted EBITDA guided to $130 million to $140 million, pointing to margins around 20%.

Exploring AI-Driven Trading Approaches

Investors looking for data-driven ways to navigate changing market conditions may find value in Tickeron’s Trending AI Robots page. I have used this resource myself to review automated strategies that align with current conditions. It surfaces only the highest-performing and most relevant bots from hundreds available, covering a range of strategies, timeframes, and risk profiles. This gives a practical starting point for observing which approaches are performing well right now without needing to sift through everything manually.

Key Items to Watch in the Months Ahead

Looking forward, Life360’s next earnings report, expected around August 10, 2026, will be an important checkpoint. I’m watching this closely for updates on MAU growth, Paying Circles net additions, advertising revenue progress, and margin expansion. The company has noted that Q4 2026 adjusted EBITDA margins should exceed the 22% achieved in Q4 2025, supported by operating leverage as advertising scales. International efforts in Mexico, Brazil, and Germany are also expected to add to results in the second half.

On the risk side, competition from Apple (AAPL) Find My and Alphabet’s (GOOGL) Find Hub, potential macroeconomic pressures on consumer spending, and execution risks around the Nativo integration and Pet GPS ramp all deserve attention. The stock’s beta above 2.0 suggests price swings could stay elevated.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: LIF

Momentum Indicator for LIF turns positive, indicating new upward trend

LIF saw its Momentum Indicator move above the 0 level on July 30, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator turned positive. In of the 32 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for LIF just turned positive on August 04, 2026. Looking at past instances where LIF's MACD turned positive, the stock continued to rise in of 21 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where LIF advanced for three days, in of 148 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 110 cases where LIF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for LIF moved out of overbought territory on August 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LIF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

LIF broke above its upper Bollinger Band on August 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LIF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.091) is normal, around the industry mean (28.085). P/E Ratio (34.086) is within average values for comparable stocks, (80.367). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.677). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (9.671) is also within normal values, averaging (68.964).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LIF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

Notable companies

The most notable companies in this group are Shopify Inc (NASDAQ:SHOP), Salesforce (NYSE:CRM), Uber Technologies (NYSE:UBER), ServiceNow Inc. (NYSE:NOW), Adobe (NASDAQ:ADBE), Intuit (NASDAQ:INTU), Datadog (NASDAQ:DDOG), Autodesk (NASDAQ:ADSK), Workday (NASDAQ:WDAY), Zoom Communications Inc (NASDAQ:ZM).

Industry description

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

Market Cap

The average market capitalization across the Packaged Software Industry is 9.77B. The market cap for tickers in the group ranges from 291 to 225.77B. SAP holds the highest valuation in this group at 225.77B. The lowest valued company is BLGI at 291.

High and low price notable news

The average weekly price growth across all stocks in the Packaged Software Industry was 5%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was 3%. YXT experienced the highest price growth at 151%, while NXTT experienced the biggest fall at -86%.

Volume

The average weekly volume growth across all stocks in the Packaged Software Industry was 23%. For the same stocks of the Industry, the average monthly volume growth was 37% and the average quarterly volume growth was -25%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 78
Price Growth Rating: 58
SMR Rating: 78
Profit Risk Rating: 94
Seasonality Score: -4 (-100 ... +100)
View a ticker or compare two or three
LIF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry PackagedSoftware

Profile
Details
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.